These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Desmopressin improves platelet dysfunction measured by in vitro closure time in uremic patients. Lee HK; Kim YJ; Jeong JU; Park JS; Chi HS; Kim SB Nephron Clin Pract; 2010; 114(4):c248-52. PubMed ID: 20090366 [TBL] [Abstract][Full Text] [Related]
4. Thrombocytopenia and subdural hemorrhage after desmopressin administration. Sun HL; Chien CC Anesthesiology; 1998 Apr; 88(4):1115-7. PubMed ID: 9579523 [No Abstract] [Full Text] [Related]
5. Effect of desmopressin (DDAVP) on protein C and protein C inhibitors in uremia. Akpolat T; Ozdemir O; Arik N; Demirkan F; Sungur C; Ozcebe O; Dündar S; Yasavul U; Turgan C; Kirazli S Nephron; 1993; 64(2):232-4. PubMed ID: 8321356 [TBL] [Abstract][Full Text] [Related]
6. [Effect of 1-deamino-8-D-arginine vasopressin (DDAVP) on bleeding time in uremic patients]. Alarcón F; Mezzano D; Vial S; Pereira J Rev Med Chil; 1985 Aug; 113(8):763-8. PubMed ID: 3938558 [No Abstract] [Full Text] [Related]
7. Reduced response of uraemic bleeding time to repeated doses of desmopressin. Canavese C; Salomone M; Pacitti A; Mangiarotti G; Calitri V Lancet; 1985 Apr; 1(8433):867-8. PubMed ID: 2858723 [No Abstract] [Full Text] [Related]
8. Hyponatremia may be an under-recognized complication after desmopressin to reduce uremic bleeding in kidney biopsy. Lim CC; Chawla M; Siow B; Choo JCJ; Lee PH; Foo M; Tan CS Nephrology (Carlton); 2019 Jun; 24(6):674. PubMed ID: 31006950 [No Abstract] [Full Text] [Related]
9. Effect of desmopressin on protein S and antithrombin III in uremia. Akpolat T; Eser M; Albayrak D; Arik N Nephron; 1997; 77(3):362. PubMed ID: 9375836 [No Abstract] [Full Text] [Related]
10. Worsening of thrombotic thromboctyopenic purpura symptoms associated with desmopressin administration. Overman M; Brass E Thromb Haemost; 2004 Oct; 92(4):886-7. PubMed ID: 15499705 [No Abstract] [Full Text] [Related]
11. DDAVP releases tPA in correlation with a fall in platelet serotonin in uraemic patients. Malyszko J; Malyszko JS; Azzadin A; Mysliwiec M; Buczko W Thromb Res; 1992 Nov; 68(3):303-8. PubMed ID: 1471076 [No Abstract] [Full Text] [Related]
12. [Oral desmopressin in the treatment of central diabetes insipidus]. Carraro A; Giusti M Minerva Med; 1993 Oct; 84(10):563. PubMed ID: 8247312 [No Abstract] [Full Text] [Related]
13. Desmopressin: a new drug for the treatment of bleeding disorders. Haas D; Nace GS J Nephrol Nurs; 1985; 2(2):72-3. PubMed ID: 3845983 [No Abstract] [Full Text] [Related]
14. Water intoxication in patients treated with desmopressin. Robson WL Pharmacotherapy; 1996; 16(5):969-70. PubMed ID: 8888098 [No Abstract] [Full Text] [Related]
16. Desmopressin for hemophilia and other coagulation disorders. Med Lett Drugs Ther; 1984 Aug; 26(669):82. PubMed ID: 6332266 [No Abstract] [Full Text] [Related]
17. Serious reaction to desmopressin in a child with cyanotic heart disease. Israels SJ; Kobrinsky NL N Engl J Med; 1989 Jun; 320(23):1563-4. PubMed ID: 2725594 [No Abstract] [Full Text] [Related]
18. [A case report. Desmopressin caused water intoxication]. Norée E; Belfrage E; Zachrisson I; Enochsson E Lakartidningen; 1994 Feb; 91(6):515-6. PubMed ID: 8114585 [No Abstract] [Full Text] [Related]
19. Hyponatremia in children treated with desmopressin. Robson WL; Leung AK Arch Pediatr Adolesc Med; 1998 Sep; 152(9):930-1. PubMed ID: 9743047 [No Abstract] [Full Text] [Related]
20. [Acute water intoxication caused by intranasal desmopressin--Minirine]. Wagner A; Skriver EB; Pedersen H Ugeskr Laeger; 1997 May; 159(19):2889. PubMed ID: 9190722 [No Abstract] [Full Text] [Related] [Next] [New Search]